Skip to main content
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.070
-0.010 (-0.25%)
At close: Oct 30, 2024, 4:00 PM
4.090
+0.020 (0.49%)
After-hours: Oct 30, 2024, 7:13 PM EDT

Prime Medicine Revenue

Prime Medicine had revenue of $591.00K in the twelve months ending June 30, 2024.

Revenue (ttm)
$591.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$2,526
Employees
234
Market Cap
518.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20205.21M--
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.55B
Emergent BioSolutions 1.10B
Varex Imaging 832.70M
Arcturus Therapeutics Holdings 163.87M
Surmodics 120.82M
Sage Therapeutics 97.24M
Cartesian Therapeutics 54.10M
Revenue Rankings

PRME News

More News